Search results
17 sty 2023 · ROSEVILLE, Minn. and SAN DIEGO, Jan. 17, 2023 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, and Cibus, a leader in precision gene editing in agriculture,...
- Calyxt Reports Fourth Quarter 2022 Financial Results and Provides ...
ROSEVILLE, Minn., March 2, 2023 /PRNewswire/ -- Calyxt, Inc....
- Calyxt Reports First Quarter 2023 Financial Results and Provides ...
ROSEVILLE, Minn., May 1, 2023 /PRNewswire/ -- Calyxt, Inc....
- Calyxt Reports Fourth Quarter 2022 Financial Results and Provides ...
2 mar 2023 · ROSEVILLE, Minn., March 2, 2023 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, today announced operating and financial results for its fourth quarter...
1 maj 2023 · ROSEVILLE, Minn., May 1, 2023 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, today announced operating and financial results for its first quarter ended...
View today's Calyxt Inc stock price and latest CLXT news and analysis. Create real-time notifications to follow any changes in the live stock price.
17 sty 2023 · New York (N.Y) – January 17, 2023 - Cellectis (Euronext Growth: ALCLS - Nasdaq: CLLS), a clinical-stage biotechnology company using its gene editing platform to deliver life-saving cell and gene therapies, announced today that Cibus Global LLC, a Delaware limited liability company (“Cibus”), and Calyxt, Inc. (NASDAQ: CLXT) (“Calyxt ...
Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services. Real time Calyxt (CLXT) stock price quote, stock graph, news & analysis.
6 mar 2023 · Signed Agreement with Global Infrastructure Partner to Enable Growth and Scale of Calyxt’s Proprietary Plant Cell Matrix and BioFactory Technologies. Additional Updates.